WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005010022) AGONIST POLYPEPTIDE OF RECEPTOR FOR ZOT AND ZONULIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/010022    International Application No.:    PCT/US2004/022753
Publication Date: 03.02.2005 International Filing Date: 15.07.2004
IPC:
C07K 5/00 (2006.01)
Applicants: UNIVERSITY OF MARYLAND, BALTIMORE [US/US]; 520 West Lombard Street, Baltimore, MD 21201 (US) (For All Designated States Except US).
FASANO, Alessio [US/US]; (US) (For US Only).
VOGEL, Stefanie, N. [US/US]; (US) (For US Only)
Inventors: FASANO, Alessio; (US).
VOGEL, Stefanie, N.; (US)
Agent: KAGAN, Sarah, A.; Banner & Witcoff, LTD., 11th Floor, 1001 G Steet, N.W., Washington, DC 20001-4597 (US)
Priority Data:
60/487,889 15.07.2003 US
Title (EN) AGONIST POLYPEPTIDE OF RECEPTOR FOR ZOT AND ZONULIN
(FR) POLYPEPTIDE AGONISTE DE RECEPTEUR DESTINE A LA TOXINE ZOT ET A LA ZONULINE
Abstract: front page image
(EN)Agonist polypeptide of a receptor protein has been identified. The agonist can be used to facilitate drug and antigen absorption. Suitable routes of administration include oral, nasal, transdermal, and intravenous. Pharmaceutical formulations may comprise a therapeutic agent or an immunogenic agent in combination with the agonist polypeptide.
(FR)Selon l'invention, un polypeptide agoniste d'une protéine de récepteur a été identifié. L'agoniste peut être utilisé de manière à faciliter l'absorption de médicament et d'antigène. Parmi les voies appropriées d'administration, on compte notamment l'administration orale, nasale, transdermique, et intraveineuse. Certaines formulations pharmaceutiques peuvent contenir un agent thérapeutique ou un agent immunogène combiné à ce polypeptide agoniste.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)